Early Natural Health Product
2017 Prescription Drug List
Current Legal Status
Prior to 2017, ibogaine was sometimes available as a natural health product, with limited regulatory oversight, leading to inconsistent safety practices.
Health Canada added ibogaine to the Prescription Drug List, classifying it as a controlled substance requiring a prescription for legal use.
Ibogaine remains unapproved for therapeutic use in Canada, with strict restrictions on commercial sale, importation, and clinical administration.
Navigating Canadian Regulations
Key facts about ibogaine's legal status in Canada and the implications for individuals and researchers.
Prescription Only
Import Restrictions
Unauthorized Operations
Ibogaine is on the Prescription Drug List, meaning it cannot be legally sold or distributed without a valid prescription from a licensed practitioner.
Personal importation of ibogaine into Canada is prohibited, and unauthorized cross-border acquisition carries significant legal risks.
No clinics or practitioners in Canada are authorized to provide ibogaine treatment. Any such operations are illegal and pose serious health risks.
Advocacy for Ethical Research
Canadian advocates continue to work towards regulated, ethics-approved clinical trials for ibogaine. This includes developing robust protocols for cardiac safety screening and patient monitoring.
Our focus is on harm reduction and scientific rigor, ensuring any future research meets the highest standards for patient safety and data integrity.